Greenland Mines Ltd
As of Oct 22, 2026, Greenland Mines is in Stage 4, the downtrend phase, now in week 21 (since May 28, 2026). It closed at $5.98, 81.5% below its 52-week high and below its 200-day average, which is falling.
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is GRML early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
GRML among Other Precious Metals & Mining14th of 17 by relative strength
All 17 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | BVN | Stage 4 · wk 1 | 75 | −14.8% |
| 2 | SLSR | Stage 4 · wk 12 | 72 | −8.9% |
| 3 | VOXR | Stage 2 · wk 3 | 69 | −12.8% |
| 4 | HL | Stage 1 · wk 9 | 62 | −22.8% |
| 5 | MTA | Stage 2 · wk 11 | 61 | −25.6% |
| 6 | TFPM | Stage 1 · wk 9 | 55 | −9.7% |
| 7 | SBSW | Stage 1 · wk 8 | 51 | −11.7% |
| 8 | ASM | Stage 4 · wk 2 | 48 | −21.0% |
| …14 | GRML | Stage 4 · wk 21 | 12 | −46.6% |
Greenland Mines: quick answers
What stage is Greenland Mines in?
As of Oct 22, 2026, Greenland Mines (GRML) is in Stage 4, the downtrend phase. It entered Stage 4 on May 28, 2026 and is in week 21. What the four stages mean
Is Greenland Mines in an uptrend?
No. Greenland Mines is in a Stage 4 downtrend. It trades 57.5% below its 200-day average, which is falling.
How far is Greenland Mines from its 52-week high?
Greenland Mines closed at $5.98 on Oct 22, 2026, 81.5% below its 52-week high of $32.30. Its 52-week low is $2.85.
How has Greenland Mines performed over the past year?
As of Oct 22, 2026, Greenland Mines is down 78.7% over the past year and down 62.6% so far in 2026.
Which sector and industry is Greenland Mines in?
Greenland Mines is in the Other Precious Metals & Mining industry, part of the Materials sector.
About this companyMaterials· Other Precious Metals & Mining
Greenland Mines Ltd engages in the cell and gene therapy, and natural resources businesses. The company primarily explores palladium, gold, and platinum deposits. It focuses on the exploration and development of Skaergaard project located in Southeast Greenland and the Sarartoq neodymium-praseodymium (Nd-Pr) rare earths project in Southwest Greenland. The company is also involved in the development of KLTO-202, a gene therapy for the treatment and prevention of amyotrophic lateral sclerosis; and KLTO-101 for the treatment or prevention of Alzheimer's disease, as well as therapies to treat Parkinson's and other age-related disorders. The company was formerly known as Klotho Neurosciences, Inc. and changed its name to Greenland Mines Ltd in March 2026. Greenland Mines Ltd is based in Charlotte, North Carolina.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.